SLC6A3 and Parkinson disease: However, some studies have shown that more severe periventricular WMHs (PWMHs) are associated with dopamine transporter loss in patients with Parkinson's disease, independent of vascular risk factors,20 and associated with the presence of LBD, independent of the presence of AD.21